Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Comvita Limited Director's Dealing 2020

Jan 22, 2020

66182_rns_2020-01-22_78df553d-dde4-4706-9bd7-9055b87317f8.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [61 x 17] intentionally omitted <==

==> picture [169 x 56] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Comvita Limited
Date this disclosure made: 22-Jan-20
Date of last disclosure: 20-Dec-19
Director or senior manager giving disclosure
Full name(s): Neil John Craig
Name of listed issuer: Comvita Limited
Name of related body corporate (if applicable): n/a
Position held in listed issuer: Company Chair
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares
Nature of the affected relevant interest(s): Beneficial owner of the shares
For that relevant interest-
Number held in class before acquisition or disposal: 19,128Neil John Craig-Start Scheme A/C
Number held in class after acquisition or disposal: 500,000Neil John Craig - Custodial Services Ltd;
20,463Neil John Craig - Start Scheme A/C;
75,000Sheryl Denise Tebbutt (Partner) - Custodial Services Ltd;
25,000Anna Beth Craig (Daughter) - Custodial Services Ltd;
440,000Neil John Craig, Sheryl Denise Tebbutt, Sharp Tudhope
Trustee Services No 27 Ltd for Eaglesham Trust - Custodial
Services Ltd
Current registered holder(s): Neil John Craig-Start Scheme A/C
Registered holder(s) once transfers are registered: Neil John Craig-Start Scheme A/C
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction: 21-Jan-20
Nature of transaction: 1,335 ordinary shares acquired pursuant to a non-discretionary fixed
trading plan, to which shares will be acquired on a monthly basis
without interruption over the next 12 months. This is the ninth
acquisition of shares pursuant to the fixed trading plan.
Name of any other party or parties to the transaction (if known): N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition $3,980
or disposal. If the consideration was not in cash and cannot be readily by converted into
a cash value,describe the consideration:
Number of financial products to which the transaction related: 1
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period: No
Whether prior written clearance was provided to allow the acquisition or disposal to N/A
proceed duringthe closedperiod:
Date of the prior written clearance (if any): N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature: 22-Jan-20

==> picture [91 x 25] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Comvita Limited
Date this disclosure made: 22-Jan-20
Date of last disclosure: 20-Dec-19

Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

Christine Mary Fleury Comvita Limited n/a Board Secretary

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Class of affected quoted financial products: Ordinary Shares
Nature of the affected relevant interest(s): Craigs Start Scheme A/C - registered holder
For that relevant interest-
Number held in class before acquisition or disposal: Craigs Start Scheme A/C - 9,482
Tutamai Trust - 110,000
Number held in class after acquisition or disposal: Craigs Start Scheme A/C-10,146
Current registered holder(s): Christine MaryFleury
Registered holder(s)once transfers are registered: Christine MaryFleury
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
21-Jan-20
664 ordinary shares acquired pursuant to a non-
discretionary fixed trading plan, to which shares
will be acquired on a monthly basis without
interruption over the next 12 months. This is
the eigth acquisition of shares pursuant to the
fixed trading plan.
n/a
$1,952
1
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:

Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod:
n/a
Date of the prior written clearance (if any): n/a
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons for
whom it is made.
Signature of director or officer:
Date of signature:
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons for
whom it is made.
Signature of director or officer:
Date of signature: 22-Jan-20